Linus Health will deliver poster presentations at AD/PD from two clinical studies evaluating the accuracy, efficacy, and ...

In an era of digital everything, the true luxury might be analog experiences: the weight of a paper bag filled with ...

Presentations will feature potential best-in-class pan-RAS molecular glue ERAS-0015 and pan-KRAS inhibitor ERAS-4001Erasca will also present ...

Quince Therapeutics, Inc. , a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, today provided an update on the company's ...

Conclusions: ATG1144 specifically binds to human CD24 with high sensitivity as demonstrated by IHC staining. The development ...